According to the NCI website, Tagraxofusp is a recombinant protein consisting of human interleukin 3 (IL3) fused to the first 388 amino acids of diphtheria toxin [DT(388)] (DT388IL3) with potential antineoplastic activity. Check for active clinical trials using this agent. (NCI Thesaurus)
- Tazemetostat is used to treat locally advanced and metastatic epithelioid sarcoma.
More Information in English:
Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to MedlinePlus, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute
Info for Patients presented by Scott Hamilton from Chemocare.com